Baike Bio Exhibits in Frankfurt: Connecting to New Global Opportunities
Release time:
2025-11-03
Recently, the global pharmaceutical industry has turned its attention to Frankfurt, Germany, where the highly authoritative CPHI Frankfurt—the premier international trade fair for pharmaceutical ingredients—successfully came to a close. This year’s event brought together industry leaders and world-class companies from around the globe, providing an efficient platform for attendees to forge critical partnerships and explore cutting-edge business opportunities.
Baike Biotech showcased the company’s three core products at the event: the live attenuated varicella vaccine, the lyophilized intranasal live attenuated influenza vaccine, and the live attenuated shingles vaccine. The mission of this exhibition is not only to deepen international market recognition of these core products but, more importantly, to comprehensively highlight the significant potential of the company’s pipeline in development and to explore the feasibility of establishing multiple collaborative partnerships.
Adhering to a dual strategy of “bringing in” and “going out,” the team has, on the one hand, actively hosted visiting distributors from numerous countries and regions, including the European Union, Saudi Arabia, Brazil, South Africa, and Russia, engaging in fruitful exchanges on product features and potential collaboration opportunities. On the other hand, the team has proactively visited several existing partners to deepen relationships and advance ongoing projects. Moreover, team members have seized valuable opportunities to initiate direct outreach with multiple prospective distributors, actively exploring additional avenues for future cooperation.
The Bio-Pharmaceutical Expo in Frankfurt has concluded successfully. Through this event, the company not only significantly enhanced its brand visibility on the international stage but also established valuable initial trust with numerous potential partners. Looking ahead, Bio-Pharmaceutical will continue to be driven by innovation, steadily advance its global expansion strategy, and actively follow up with prospective clients engaged during the exhibition. The company is committed to translating collaborative agreements into concrete outcomes, working hand-in-hand with all stakeholders to contribute to the healthy development of the global pharmaceutical market.
Keywords:
Recommended News